Gain of the CCND1 and CDK4 and loss of the CDKN2A (p16) and CDKN2C (p18) genes are present in patients with luminal B breast cancer and poor prognosis of and negatively regulated by the cell cycle pathway29. This evidence concerns the gene CDKN2C and breast cancer.